参考文献/References:
[1] Wang X,Fu Q,Song F,et al.Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke:results from a national stroke screening survey[J].Int J Cardiol,2018,271:92-97.
[2] Long V,Guertin MC,Dyrda K,et al.Descriptive study of anxiety and posttraumatic stress disorders in cardiovascular disease patients: from referral to cardiopsychiatric diagnoses[J].Psychother Psychosom,2018,87(6):370-371.
[3] Kirchhof P.The future of atrial fibrillation management: integrated care and stratified therapy[J].Lancet,2017,390(10105):1873-1887.
[4] Thrall G,Lip GY,Carroll D,et al.Depression, anxiety, and quality of life in patients withatrial fibrillation[J].Chest,2007,132(4):1259-1264.
[5] Serpytis R,Navickaite A,Serpytiene E,et al. Impact of atrial fibrillation on cognitive function, psychological distress, quality of life, and impulsiveness[J].Am J Med,2018,131(6):703.e1-703.e5.
[6] Bostrom JA,Saczynski JS,Hajduk A,et al. Burden of psychosocial and cognitive impairment in patients with atrial fibrillation[J].Crit Pathw Cardiol,2017,16(2):71-75.
[7] Gleason KT,Dennison Himmelfarb CR,Ford DE,et al. Association of sex, age and education level with patient reported outcomes in atrial fibrillation[J].BMC Cardiovasc Disord,2019,19(1):85.
[8] Gehi AK,Sears S,Goli N,et al. Psychopathology and symptoms of atrial fibrillation: implications for therapy[J].J Cardiovasc Electrophysiol,2012,23(5):473-478.
[9] Polikandrioti M,Koutelekos I,Vasilopoulos G,et al. Anxiety and depression in patients with permanent atrial fibrillation: prevalence and associated factors[J].Cardiol Res Pract,2018,2018:7408129.
[10] Kurokawa J,Kodama M,Clancy CE,et al. Sex hormonal regulation of cardiac ion channels in drug-induced QT syndromes[J].Pharmacol Ther,2016,168:23-28.
[11] Sang CH,Chen K,Pang XF,et al. Depression, anxiety, and quality of life after catheter ablation in patients with paroxysmal atrial fibrillation[J].Heart,2013,99:E195-E196.
[12] Yu S,Zhao Q,Wu P,et al. Effect of anxiety and depression on the recurrence of paroxysmal atrial fibrillation after circumferential pulmonary vein ablation[J].J Cardiovasc Electrophysiol,2012,23:S17-23.
[13] Yu S,Hu W,Zhao Q,et al. Effect of anxiety and depression on the recurrence of persistent atrial fibrillation after circumferential pulmonary vein ablation[J].Chin Med J(Engl),2012,125(24):4368-4372.
[14] Cosansu K,Ureyen CM,Y?lmaz S. Effect of novel oral anticoagulants on Hospital Anxiety and Depression Scale scores[J].Herz,2019,44(8):743-749.
[15] Fumagalli S,Cardini F,Roberts AT,et al. Psychological effects of treatment with new oral anticoagulants in elderly patients with atrial fibrillation: a preliminary report[J].Aging Clin Exp Res,2015,27(1):99-102.
[16] Frasure-Smith N,Lesperance F,Talajic M,et al. Anxiety sensitivity moderates prognosticimportance of rhythm-control versus rate-control strategies in patients with atrial fibrillationand congestive heart failure: insights from the Atrial Fibrillation and Congestive Heart Failure Trial[J].Circ Heart Fail,2012,5(3):322-330.
[17] Lakkireddy D,Atkins D,Pillarisetti J,et al. Effect of yoga on arrhythmia burden, anxiety, depression, and quality of life in paroxysmal atrial fibrillation:the YOGA My Heart Study[J].J Am Coll Cardiol,2013,61(11):1177-1182.
[18] Dudink EAMP, Erküner ?,Berg J,et al. The influence of progression of atrial fibrillation onquality of life: a report from the Euro Heart Survey[J].Europace,2018,20(6):929-934.
[19] Charitakis E,Barmano N,Walfridsson U,et al.Factors predicting arrhythmia-related symptoms and Health-Related Quality of Life in patients referred for radiofrequency ablation of atrial fibrillation:an observational study (the SMURF Study)[J].JACC Clin Electrophysiol,2017,3(5):494-502.
[20] Mohanty S,Trivedi C,Gianni C,et al. Impact of baseline anxiety on arrhythmia-free survival and quality of life in atrial fibrillation patients undergoing catheter ablation[J].J Am Coll Cardiol,2018,71(11):348.
[21] Son YJ,Baek KH,Lee SJ,et al. Health-related quality of life and associated factors in patients with atrial fibrillation: an integrative literature review[J].Int J Environ Res Public Health,2019,16(17):M31443363.
[22] Jia Z,Du X,Lu S,et al. Effect of mental health status on arrhythmia recurrence after catheter ablation of atrial fibrillation[J].Can J Cardiol,2019,35(7):831-839.
[23] Feng T,Malmo V,Laugsand LE,et al. Symptoms of anxiety and depression and risk of atrial fibrillation-The HUNT study[J].Int J Cardiol,2019,306:95-100.
[24] Garg PK,O’Neal WT,Diez-Roux AV,et al. Negative affect and risk of atrial fibrillation:MESA[J].J Am Heart Assoc,2019,8(1):e010603.
[25] Marott SC,Nordestgaard BG,Zacho J,et al. Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population[J].J Am Coll Cardiol,2010,56(10):789-795.
[26] Schnabel RB,Larson MG,Yamamoto JF,et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community[J].Circulation,2010,121(2):200-207.
[27] Renna ME,O’toole MS,Spaeth PE,et al. The association between anxiety, traumatic stress, and obsessive-compulsive disorders and chronic inf lammation: A systematic review and meta-analysis[J].Depress Anxiety,2018,35(11):1081-1094.
[28] Michopoulos V,Powers A,Gillespie CF,et al. Inflammation in fear-and anxiety-based disorders:PTSD,GAD,and Beyond[J].Neuropsychopharmacology,2017,42(1):254-270.
[29] Liu F,Havens J,Yu Q,et al. The link between angiotensin II-mediated anxiety and mood disorders with NADPH oxidase-induced oxidative stress[J].Int J Physiol Pathophysiol Pharmacol,2012,4(1):28-35.
[30] Takahashi N,Kume O,Wakisaka O,et al.Novel strategy to prevent atrial fibrosis and fibrillation[J].Circ J,2012,76(10):2318-2326.
[31] Iravanian S,Dudley SC. The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias[J].Heart Rhythm,2008,5(6 suppl):S12-17.
[32] Marott SC,Nielsen SF,Benn M, et al. Antihypertensive treatment and risk of atrial fibrillation: a nationwide study[J].Eur Heart J,2014,35(18):1205-1214.
[33] Healey JS,Baranchuk A,Crystal E,et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin recep tor blockers:a meta-analysis[J].J Am Coll Cardiol,2005,45(11):1832-1839.
[34] Shen MJ,Zipes DP. Role of the autonomic nervous system in modulating cardiac arrhythmias[J].Circ Res,2014,114(6):1004-1021.
[35] Fioranelli M,Piccoli M,Mileto GM,et al. Analysis of heart rate variability five minutesbefore the onset of paroxysmal atrial fibrillation[J].Pacing Clin Electrophysiol,1999,22(5):743-749.
[36] Kemp AH,Brunoni AR,Santos IS,et al. Effects of depression, anxiety, comorbidity, andantidepressants on resting-state heart rate and its variability:an ELSA-Brasil cohort baseline study[J].Am J Psychiatry,2014,171(12):1328-1334.
[37] Kemp AH,Quintana DS. The relationship between mental and physical health: insightsfrom the study of heart rate variability[J].Int J Psychophysiol,2013,89(3):288-296.
[38] Hansen C,Zinckernagel L,Schneekloth N,et al. The association between supportive relatives and lower occurrence of anxiety and depression in heart patients: Results from a nationwide survey[J].Eur J Cardiovasc Nurs,2017,16(8):733-741.
[39] Alvares GA,Quintana DS,Kemp AH,et al. Reduced heart rate variability in social anxiety disorder: associations with gender and symptom severity[J].PLoS One,2013,8(7):e70468.
[40] Summers MR,Lennon RJ,Prasad A. Pre-morbid psychiatric and cardiovascular diseases in apical ballooning syndrome (tako-tsubo/stress-induced cardiomyopathy): potential pre-disposing factors?[J].J Am Coll Cardiol,2010,55(7):700-701.
[41] Pal S,Broker M,Wagner H,et al. Stress(Takotsubo) cardiomyopathy:a review of its pathophysiology, manifestations, and factors that affect prognosis[J].Cardiol Rev,2020 Mar 19.doi:10.1097/CRD.0000000000000309.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(2):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(2):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(2):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(2):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(2):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]